胸痹通胶囊治疗PCI术后再发心绞痛的疗效视察.pdf

提 要 目的：本论文主要研究胸痹通胶囊治疗PCI术后再发心绞痛的疗效观察。 方法：临床研究中，将 60 例 PCI 术后再发心绞痛的患者纳入观察病例，并随机 分为两组，两组患者均给与拜阿司匹灵、舒降之、波利维、鲁南欣康口服药物。治疗 组在常规西药治疗基础上加服胸痹通胶囊 （由潍坊市中医医院制剂中心生产），一次 4粒，一日3次。伴有高血压、糖尿病患者给予相应的对症支持治疗。治疗4周后， 对入组患者进行临床症状、心电图改变的观察，并检测实验室指标，进行治疗前后的 对比，并通过相应的统计学对结果做进一步的分析。 结果：1.在PCI术后再发心绞痛的缓解症状和改善心电图方面，两组均有显著的 疗效，治疗组的疗效要优于对照组。2.在改善中医症状方面，通过中医症候积分疗效 评价，治疗组明显优于对照组。3.在血脂总胆固醇、甘油三酯及低密度脂蛋白检测方 面，治疗后两组均有下降，并治疗组下降更明显。 结论：通过临床观察，及各种指标检测，胸痹通胶囊是临床上治疗PCI术后再发 心绞痛的一个安全、疗效确切的中药复方制剂，并因中药的毒副作用小及整体调治的 特点，其应用前景广阔，优越性无法比拟，为中医药治疗 PCI 术后心绞痛提供新的思 路和方法，同时也进一步完善胸痹通胶囊的临床应用范围。 关键词 冠心病心绞痛；PCI术后再发心绞痛；胸痹通胶囊；中医药治疗 Xiongbitong capsule in treatment of angina pectoris after PCI observation Speciality: Internal Medicine of TCM Author ：Wang Wen Tutor：Professor Tang Keqing Abstract Objective: This paper mainly studies of xiongbitong capsule in the treatment of angina pectoris after PCI operation observation. Methods: In clinical studies, after PCI in patients with angina pectoris 60 example randomly divided into two groups, 60 into the case, and two groups of patients were given the oral drugs.of aspirin, simvastatin, Polivy, and lunanxinkang (manufactured by Weifang traditional Chinese Medicine Hospital), 4 capsules, 3 times a day. Support for relative accompanied by high blood pressure, diabetes treatment. After 4 weeks, watch before and after clinical symptoms and St-t changes of ECG, laboratory test index, and for statistical analysis. Results: 1. the two groups to improve symptom relief and electrocardiogram of angina have a significant effect, efficacy of the treatment group than the control group. 2. the two groups in terms of improved symptoms of traditional Chinese Medicine, treatment significantly better than c